Fucosylation Is a Promising Target for Cancer Diagnosis and Therapy

Author： Miyoshi Eiji Moriwaki Kenta Terao Naoko Tan Cheng-Cheng Terao Mika Nakagawa Tsutomu Matsumoto Hitoshi Shinzaki Shinichiro Kamada Yoshihiro

Publisher： MDPI

E-ISSN： 2218-273x|2|1|34-45

ISSN： 2218-273x

Source： Biomolecules, Vol.2, Iss.1, 2012-01, pp. : 34-45

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EZH2 in Bladder Cancer, a Promising Therapeutic Target

By Martínez-Fernández Mónica Rubio Carolina Segovia Cristina López-Calderón Fernando F. Dueñas Marta Paramio Jesús M.

International Journal of Molecular Sciences, Vol. 16, Iss. 11, 2015-11 ,pp. : 27107-27132

MDPI

Access to resources Recommend Favorite

Survivin as a Preferential Target for Cancer Therapy

By Mobahat Mahsa Narendran Aru Riabowol Karl

International Journal of Molecular Sciences, Vol. 15, Iss. 2, 2014-02 ,pp. : 2494-2516

MDPI

Access to resources Recommend Favorite

Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy

By Rwibasira Rudinga Gamariel Khan Ghulam Jilany Kong Yi

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 573-573

MDPI

Access to resources Recommend Favorite

Mitochondrial Peroxiredoxin III is a Potential Target for Cancer Therapy

By Song In-Sung Kim Hyoung-Kyu Jeong Seung-Hun Lee Sung-Ryul Kim Nari Rhee Byoung Doo Ko Kyung Soo Han Jin

International Journal of Molecular Sciences, Vol. 12, Iss. 10, 2011-10 ,pp. : 7163-7185

MDPI

Access to resources Recommend Favorite

Molecular Approaches To Target GPCRs in Cancer Therapy

By Innamorati Giulio Valenti Maria Teresa Giovinazzo Francesco Carbonare Luca Dalle Parenti Marco Bassi Claudio

Pharmaceuticals, Vol. 4, Iss. 4, 2011-03 ,pp. : 567-589

MDPI

Access to resources Recommend Favorite